Ewp Pharma & Lifecare Remedies Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
as on 02-11-2024
- Paid Up Capital ₹ 9.10 Cr
as on 02-11-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 2788.52%
(FY 2023)
- Profit 99.21%
(FY 2023)
- Ebitda 99.20%
(FY 2023)
- Net Worth 33840.10%
(FY 2023)
- Total Assets 1703.31%
(FY 2023)
About Ewp Pharma & Lifecare Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.50 Cr and a paid-up capital of Rs 9.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Balaraman Mohankumar and Sabarish Mohankumar serve as directors at the Company.
- CIN/LLPIN
U24230TZ2019PTC031881
- Company No.
031881
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ewp Pharma & Lifecare Remedies?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sabarish Mohankumar | Director | 25-Mar-2019 | Current |
Balaraman Mohankumar | Director | 25-Mar-2019 | Current |
Financial Performance of Ewp Pharma & Lifecare Remedies.
Ewp Pharma & Lifecare Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2788.52% increase. The company also saw a substantial improvement in profitability, with a 99.21% increase in profit. The company's net worth Soared by an impressive increase of 33840.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ewp Pharma & Lifecare Remedies?
In 2023, Ewp Pharma & Lifecare Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Omkar Medical Distributors Private LimitedActive 17 years 7 months
Balaraman Mohankumar is a mutual person
- East West Pharma India Private LimitedActive 4 years 11 months
Balaraman Mohankumar and Sabarish Mohankumar are mutual person
- Vedhsang Private LimitedActive 2 years 20 days
Balaraman Mohankumar and Sabarish Mohankumar are mutual person
- East West Ethicals Private LimitedActive 4 years 7 months
Balaraman Mohankumar and Sabarish Mohankumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ewp Pharma & Lifecare Remedies?
Unlock and access historical data on people associated with Ewp Pharma & Lifecare Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ewp Pharma & Lifecare Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ewp Pharma & Lifecare Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.